Histidine-rich glycoprotein (HRGP), a plasma protein with antiheparin and antifibrinolytic activity, has been associated with thrombophilia in three families. Therefore, it may promote hypercoagulability. The following objectives have been achieved in the laboratory: purification of HRGP, development of an enzyme-linked immunosorbent assay for its quantitation, and confirmation of its antiheparin activity. In addition, we have discovered that some individuals have a single isoform of HRGP, while others have two forms. Preliminary work indicates that the differences represent heterogeneity of the oligosaccharide chains of this glycoprotein. An ongoing project is the study of HRGP binding to proteins that contain a """"""""kringle"""""""" structure, such as plasminogen. By identifying binding sites for HRGP, we hope to discover potential functions for this protein.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010220-04
Application #
2571422
Study Section
Cognition and Perception Study Section (CP)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Horne 3rd, M K; Merryman, P K; Cullinane, A M (2001) Histidine-proline-rich glycoprotein binding to platelets mediated by transition metals. Thromb Haemost 85:890-5